GLP-1/GIP agonists have exploded with both positive and negative impacts for our practices. Additionally, they’ve brought attention to incretin hormones highlighting the need for practitioners to optimize endogenous production regardless of medication usage. So the question to you is – but how and for whom and when? Who is a good candidate? What protocol can I use to evaluate, prescribe, monitor them and optimize their results including deprescribing with maintenance? In this session, Ashley Koff RD of The Better Nutrition Program and Darshan Shah MD of Next Health will share their evidence and practice-based experience, leaving time for your questions.
- Evaluate a patient & implement a protocol for optimization of endogenous GLP-1.
- Evaluate a patient & implement a protocol for GLP-1/GIP agonist medication.
- Identify the essential roles of team members required for successful implementation of these protocols.